Mannkind Corporation

Patents = 275

Trademarks = 59

Forward Citations = 4,669

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

244 inventors (with patents filed for the assignee):

MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of therapeutic products for patients with diseases such as diabetes. Their flagship product, Afrezza, is an inhaled insulin used to improve glycemic control in adults with diabetes mellitus. MannKind Corporation strives to advance healthcare solutions through innovative and accessible treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com